31 Jan 2022 – Melbourne, Victoria, Australia

Global Boost to Australia’s Revolutionary Bionic Eye Technology

Australia’s world-first Bionic Eye System has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA) in the United States.

Created by Bionic Vision Technologies (BVT), the Centre for Eye Research Australia, the Bionics Institute, CSIRO’s Data61 and the University of Melbourne, this groundbreaking technology aims to give functional vision to millions of people who have lost their sight due to the genetic condition, Retinitis Pigmentosa (RP).

The FDA’s Breakthrough Devices Program speeds up the review and assessment of medical devices which provide “more effective treatment” than any alternatives currently available.

“This is a significant achievement and a key milestone for BVT,” CEO Dr Ash Attia said. “The life-changing bionic eye can be brought more quickly to the people who need it the most.”
Tiny cameras, embedded within a pair of glasses, send electrical signals to a wearable proces- sor. The processor transmits to an implant behind the retina, delivering visual information to the blind person, giving them functional vision.

A recently published peer-reviewed two-year study focused on four Australians using the bi- onic eye. They reported being able to recognise their loved ones in a cafe, identify vacant chairs, sort their washing, and identify surroundings such as traffic lights, cars, people, trees, and street poles.

Download the full media release